Zavedos, known generically as idarubicin, is a type of chemotherapy medication used primarily in the treatment of various forms of leukemia, including acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL). It belongs to the anthracycline class of drugs, which work by interfering with the DNA replication process in cancer cells, thereby inhibiting their growth and proliferation. Zavedos is administered intravenously and is often used in combination with other chemotherapy medications as part of a comprehensive treatment regimen. Like other chemotherapy drugs, Zavedos can have significant side effects, including lowering the body's ability to fight infections, nausea, vomiting, and hair loss, among others. Its use and dosage are carefully determined by a healthcare professional based on the specific condition being treated and the patient's overall health.